Citadel Advisors
REVBU

Citadel Advisors’s Revelation Biosciences, Inc. Unit REVBU Stock Holding History

Citadel Advisors’s Portfolio REVBU Stock Details REVBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-17,315
Closed -$3.46K – 7050
2022
Q4 		$3.46K Buy
+17,315
New +$3.46K ﹤0.01% 5832